Peltonen JK, V ähäkangas KH, Helppi HM, Bloigu R, Pääkkö P, Turpeenniemi-Hujanen T. Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study. Head Neck Oncol. 2011 Apr 22;3:20.

Conclusions These data indicate that a TP53 mutation in L2, L3 or LSH is worth pursuing as a marker for predicting prognosis and response to radiation among HNSCC patients.

http://www.oapublishinglondon.com/article/137

Source: Head and Neck Oncology - July 21, 2016 Category: Cancer & Oncology Source Type: research